Jaap Stuut

Chief Executive Officer (IDS)

Jaap has been with the Company since 2013 and was previously responsible for the global marketing and corporate development of the Company, as well as having the direct sales responsibility for the USA and Brazil. Prior to this, he was responsible for global marketing.

Before joining IDS, Jaap worked at SHO Centra for Medical Diagnostics where he held the position of Chief Operating Officer. He was responsible for Sales, Marketing and Operations. Additionally he worked at Roche Diagnostics where he held several senior Sales & Marketing roles in the Clinical Medical Diagnostics team. Jaap is a Dutch national and holds an MBA from Bradford University School of Management.

Mr Paul Martin

Finance Director and Company Secretary

Paul joined IDS as Finance Director on 4 January 2016. Previously Paul was based in Singapore as CFO of Volex plc’s Power Division, a major manufacturer of electrical power cables with operations throughout Asia.

Paul qualified as a Chartered Accountant with Deloitte in 2002, and subsequently worked in a number of senior finance roles in the technology sector

Wolfgang Schlumberger, PhD

Chief Executive Officer (Euroimmun)

Wolfgang Schlumberger became a member of the IDS Board of Directors in July 2021. He is Chief Executive Officer at EUROIMMUN Medizinische Labordiagnostika AG. In 1991, Wolfgang Schlumberger joined EUROIMMUN with responsibilities for research and development of enzyme immunoassays. He became director of the division Immunobiochemical Diagnostics in 1996 and has been a member of the Board of Directors since 2003. In 2013, he was appointed as vice chairman of the Board and took over the chairmanship in 2019.

Wolfgang Schlumberger graduated in Biology and Philosophy in 1985 and received his doctoral degree in Biology at the University of Münster, Germany,  in 1989.